Asia Pacific Maqui Berries Market
Asia Pacific Maqui Berries Market is growing at a CAGR of 12.2% to reach US$ 24.02 million by 2030 from US$ 9.56 million in 2022 by Form, Category, and Application .

Published On: Jun 2024

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Maqui Berries Market

At 12.2% CAGR, Asia Pacific Maqui Berries Market is Projected to be Worth US$ 24.02 Million by 2030, says Business Market Insights

According to Business Market Insights research, the Asia Pacific maqui berries market was valued at US$ 9.56 million in 2022 and is expected to reach US$ 24.02 million by 2030, registering a CAGR of 12.2% from 2022 to 2030. Utilization of maqui berries in supplements for diabetes and increasing use of maqui berries in functional food & beverages are among the critical factor attributed to the Asia Pacific maqui berries market expansion.        

Over the past few years, the prevalence of diabetes has increased significantly due to lack of physical activity, rising consumption of junk food, increasing prevalence of obesity, and stressful lifestyle of consumers. Diabetes can lead to serious health conditions such as heart attack and stroke, vision loss, and kidney diseases, if not treated and controlled early. Many treatments and medications have been discovered for diabetes. However, scientists are still working to find natural remedies with high efficiency to cure diabetes and regulate blood sugar level. Maqui berries are rich in anthocyanins, polyphenols, and delphinidin that help neutralize free radicals, boost immunity, prevent cancer, and reduce excessive blood sugar. Maqui berries are the richest sources of anthocyanins with 25% of cyanidins and 75% of delphinidin composition. They comprise the highest delphinidin content among all the berries.

Delphinidin Content of “Superfruit” Berries

Sr No

Superfruit

(Common Name/Botanical Name)

Delphinidin Content

(in mg /100 g of raw fruit)

1

Maqui Berry/Aristotelia chilensis

126,00

2

Bilberry/Vaccinium myrtillus

97.59

3

Concord Grape/Vitis vinifera

70.62

4

Cultivated Blueberry/Highbush vaccinium spp

35.43

5

Aronia or Chockeberry/Aronia melanocarpa

0.65

6

Acai/Euterpe oleraceae

0

Source: The United Stated Department of Agriculture (USDA) Database for the Flavonoid Content of Selected Food Release

 

Delphinidin is extensively researched for its beneficial health effects, one of which is reducing postprandial blood glucose increase in individuals with impaired glucose regulation. Delphinol, a standardized maqui berry extract produced by Anklam Extrakt GmbH, has been studied to prevent blood sugar spikes and cure type-2 diabetes and other complications. In December 2022, MD Process launched GlucoBerry, a proprietary formula based on the extract of maqui berry that helps manage blood sugar through its antioxidant effects that support kidney in filtering the sugar out of the bloodstream. This mechanism also helps insulin perform its functions effectively. Thus, there is a rising demand for maqui berries to develop supplements and medications for diabetes, which propels the Asia Pacific maqui berries market.

On the contrary, limited supply of maqui berries hampers the growth of Asia Pacific Maqui Berries market.  

Based on form, the Asia Pacific maqui berries market is bifurcated into fresh and processed. The processed segment held 95.1% share of Asia Pacific maqui berries market in 2022, amassing US$ 9.09 million. It is projected to garner US$ 22.90 million by 2030 to expand at 12.2% CAGR during 2022–2030. 

In terms of category, the Asia Pacific maqui berries market is bifurcated into organic and conventional. The conventional segment held 77.7% share of Asia Pacific maqui berries market in 2022, amassing US$ 7.43 million. It is projected to garner US$ 18.41 million by 2030 to expand at 12.0% CAGR during 2022–2030.

By application, the Asia Pacific maqui berries market is segmented into functional food and beverages, pharmaceuticals and nutraceuticals, personal care and cosmetics and animal nutrition. The functional food and beverages segment held 56.3% share of Asia Pacific M maqui berries market in 2022, amassing US$ 5.38 million. It is projected to garner US$ 13.25 million by 2030 to expand at 11.9% CAGR during 2022–2030.

Based on country, the Asia Pacific maqui berries market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that the Rest of Asia Pacific captured 34.1% share of Asia Pacific maqui berries market in 2022. It was assessed at US$ 3.26 million in 2022 and is likely to hit US$ 7.61 million by 2030, exhibiting a CAGR of 11.2% during 2022–2030.

Key players operating in the Asia Pacific maqui berries market are HP Ingredients Corp, Jeeva Organic Pvt Ltd, Shaanxi LonierHerb Bio-Technology Co Ltd, and Xi'an Herb Bio-Tech Co Ltd, among others.

 

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com